Advanced Prostate Cancer

/Advanced Prostate Cancer

Prostate Cancer And Agent Orange Is Not The Only Military Concern

Agent Orange is usually the first thing veterans with prostate cancer ask about.   Indeed, way back in 1998, Malecare was an early advocate for men exposed to Agent Orange. Military veterans as well as Vietnamese, Cambodian and Laotian civilians were exposed to Agent Orange, and many of those who are men are now diagnosed, [...]

By | 2018-05-25T21:26:11+00:00 May 25th, 2018|Advanced Prostate Cancer, Advocacy, Research|0 Comments

Erleada- New Treatment for Non-Metastatic Castrate Resistant Prostate Cancer

Erleada (apalutamide) has just received FDA approval as a drug for treating men with non-metastatic castration-resistant prostate cancer.   The proper pronunciation is Er ( Errr), (Like Her without the h) ) (lee) (long E) da. Now, repeat after me, "Erleada!" It's a pill that you take - I believe - four times a [...]

Apalutamide Looking Good as Treatment for Non-Metastatic Castrate Resistant Prostate Cancer

Non-Metastatic Castrate Resistant Prostate Cancer (nmCRPC)  usually leads to metastatic prostate cancer and death. There are no approved treatments for nmCRPC. Apalutamide is a taken-by-mouth androgen receptor inhibitor with antitumor activity in CRPC. There's a much talked and written about clinical trial called, SPARTAN, that investigated how well Apalutamide works on maintaining metastasis-free survival (MFS) [...]

XTANDI (enzalutamide) plus androgen deprivation therapy (ADT) reduces developing metastases or death

Non-metastatic Castrate Resistant prostate cancer patients take note.  The Phase 3 PROSPER trial in patients with non-metastatic (M0) Castration-Resistant Prostate Cancer (CRPC) showed that the use of XTANDI® (enzalutamide) plus androgen deprivation therapy (ADT) significantly reduced the risk of developing metastases or death by 71 percent compared to ADT alone.  It will be a [...]

Metastatic Prostate Cancer – Bone Metastases Might Be Controled With Xofigo For Two or More Years

Metastatic Prostate Cancer suffers have good news.  Xofigo, also known as Radium-223 (Ra-223), is a treatment for patients with castration-resistant prostate cancer (CRPC) and symptomatic (you can feel them) bone metastases (mets).  Early results of an international, open-label, phase 1/2 study (NCT01934790) showed that re-treating pts with Ra-223 was well tolerated with favorable effects on [...]

By | 2018-02-06T11:09:18+00:00 February 5th, 2018|Advanced Prostate Cancer, Hormone Therapy|0 Comments

Prostate Cancer And Anger

Anger hurts prostate cancer treatment.  I feel angry and I'm not going to take my pills or show up for IMRT session.   The thing about prostate cancer is that you’re not told what to do every step of the way or how to do it. Nothing is planned out for you, you just [...]

By | 2018-02-01T11:18:25+00:00 February 1st, 2018|Advanced Prostate Cancer|1 Comment

Prostate Cancer Estate and Healthcare Proxy Planning

Five Estate Planning Documents to Have When You’re Battling an Illness Whether you’re young, old, healthy, or ill, estate planning should be a top priority. However, if you’re faced with a prostate cancer or have received some other unfavorable medical diagnosis, it’s especially critical that your legal affairs are in order and up to [...]

By | 2018-01-30T08:48:31+00:00 January 30th, 2018|Advanced Prostate Cancer|0 Comments

Living Brilliantly With Prostate Cancer

      In the twenty years since I led Malecare’s first prostate cancer support group, this is the first time I have written an annual letter. Through the upturns and downturns, Malecare has always been a voice of optimism and powerful advocate for men diagnosed with prostate cancer. As we enter 2018, we are [...]

By | 2018-01-28T14:58:31+00:00 January 28th, 2018|Advanced Prostate Cancer|0 Comments

Clinical Trial Search

Searching for clinical trials is almost as hard as participating in clinical trials.  clinical trial.gov is almost unusable.  There are several businesses that have tried to make searching for clinical trials easier.  Malecare is working with two of the very best.  One, we can't tell you about in detail, since they are still in [...]

By | 2018-01-25T10:52:39+00:00 January 22nd, 2018|Advanced Prostate Cancer|0 Comments

Advanced Prostate Cancer and Cholesterol

High serum levels of total and HDL cholesterol are associated with an elevated risk of advanced prostate cancer. Every 10mg/dl increase in serum total cholesterol adds a 5% increase to your odds of being diagnosed with advanced stage prostate cancer. Every 10mg/dl increase in HDL cholesterol increases your odds of having advanced stage prostate [...]

By | 2018-01-10T12:59:05+00:00 January 10th, 2018|Advanced Prostate Cancer|0 Comments